The scientists centered on a subset of People sufferers — about one,seven hundred — who possibly experienced diabetes, were overweight or had weight problems, and compared results immediately after 36 months in people who were being prescribed semaglutide to individuals that weren’t. Semaglutide would be the component in copyright and Wegovy.